tradingkey.logo

AVITA Medical Inc

RCEL
3.840USD
-0.060-1.54%
交易中 美东报价延迟15分钟
585.47M总市值
亏损市盈率 TTM

AVITA Medical Inc

3.840
-0.060-1.54%

关于 AVITA Medical Inc 公司

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

AVITA Medical Inc简介

公司代码RCEL
公司名称AVITA Medical Inc
上市日期Mar 18, 2012
CEOVance (Cary G)
员工数量260
证券类型Ordinary Share
年结日Mar 18
公司地址28159 Avenue Stanford
城市VALENCIA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编91355
电话16613679170
网址https://www.avitamedical.com/
公司代码RCEL
上市日期Mar 18, 2012
CEOVance (Cary G)

AVITA Medical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
16.03M
93.96%
Japan
605.00K
3.55%
United Kingdom
345.00K
2.02%
Australia
80.00K
0.47%
European Union (Region)
0.00
0.00%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月4日 周四
更新时间: 12月4日 周四
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
4.74%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
其他
88.76%
持股股东
持股股东
占比
The Vanguard Group, Inc.
4.74%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
其他
88.76%
股东类型
持股股东
占比
Investment Advisor
10.83%
Investment Advisor/Hedge Fund
4.52%
Individual Investor
0.80%
Research Firm
0.74%
Hedge Fund
0.62%
Pension Fund
0.25%
Bank and Trust
0.24%
Venture Capital
0.08%
其他
81.93%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
208
5.28M
17.32%
-4.18M
2025Q3
206
7.68M
25.17%
-2.00M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
1.37M
4.48%
-84.89K
-5.85%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.07M
3.51%
-668.22K
-38.45%
Sep 30, 2025
State Street Investment Management (US)
423.31K
1.39%
-105.48K
-19.95%
Sep 30, 2025
Geode Capital Management, L.L.C.
331.46K
1.09%
-286.88K
-46.39%
Sep 30, 2025
Northern Trust Investments, Inc.
158.78K
0.52%
-83.25K
-34.40%
Sep 30, 2025
Millennium Management LLC
132.71K
0.44%
-236.48K
-64.05%
Sep 30, 2025
AQR Capital Management, LLC
119.29K
0.39%
+97.36K
+444.12%
Sep 30, 2025
Bridgeway Capital Management, LLC
118.00K
0.39%
+80.40K
+213.84%
Sep 30, 2025
Divisadero Street Capital Management, LP
100.00K
0.33%
+100.00K
--
Sep 30, 2025
HRT Financial LP
93.03K
0.31%
+93.03K
--
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
查看更多
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.02%
iShares Micro-Cap ETF
占比0.01%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
ProShares UltraPro Russell2000
占比0%
iShares Russell 3000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
iShares Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
Global X Russell 2000 ETF
占比0%
Direxion Daily S&P Biotech Bull 3X Shares
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI